Every industrial revolution has a birthplace. The steam engine had Birmingham. The microchip had Silicon Valley. The circular economy now has Valladolid. Inside this quiet corner of Spain, a ...

Strong Interactive Momentum and Strategic Evolution Position Inspired for Growth and Margin Expansion Revenue of $86.2 ...

MARYSVILLE, Ohio, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced its ...

After losing his job at a large investment firm, the former Liberal Party leader has turned for work to a small American ...

This study presents valuable findings from a spatiotemporal analysis of arbovirus case notification data from 2013 to 2020 in Brazil, reporting associations between covariates representing potential ...

Choice Hotels International, Inc. ("Choice" or "the Company") , a leading global lodging franchisor, today reported results for the third quarter ended September 30, ...

Detailed price information for Scilex Holding Co. (SCLX-Q) from The Globe and Mail including charting and trades.

Software & Services revenue grows 41% to $305 million Annual recurring revenue grows 41% to $1.3 billion Net loss was $2 million, with non-GAAP net income of $98 million and Adjusted EBITDA of $177 ...

Q3 2025 Earnings Call November 4, 2025 8:30 AM ESTCompany ParticipantsSoham Bhonsle - Head of Investor RelationsRobert Reffkin ...

Delivers 2.3% Global Net Room Growth, Driven by 3.3% Expansion in Higher Revenue Segments Accelerates International Growth with Portfolio Surpassing 150,000 Rooms Increases Global Franchise ...

DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Inspirato Incorporated (“Inspirato” or the “Company”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today reported results ...

ORX750: Demonstrated potential best-in-class profile for treatment of narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH) in initial cohorts of ongoing Phase 2a study; ...